Knoop M, Lüsebrink R, Langrehr J M, König V, Berg T, Wedell A, Hopf U, Neuhaus P
Department of Surgery, University Hospital Rudolf Virchow, Free University of Berlin, Germany.
Transpl Int. 1994;7 Suppl 1:S221-3. doi: 10.1111/j.1432-2277.1994.tb01351.x.
From September 1988 to November 1992 318 liver transplants were performed at our hospital. Of these patients 68 had end-stage cirrhosis due to non-A, non-B, hepatitis, 44 of whom (64.7%) had hepatitis C virus RNA in the serum. Of this subgroup 35 patients (79.5%) were also anti-HCV positive. Postoperatively most recipients remained anti-HCV positive and after 1 year more than 90% had HCV RNA in the serum. About 40% developed a mild, chronic hepatitis and 50% were carriers of HCV without histopathological signs. Two patients suffered from a temporary severe acute hepatitis and one patient had a fulminant liver failure due to reinfection. In general, in liver recipients transplanted for end-stage HCV hepatitis there was a high incidence of reinfection with HCV. The clinical course, however, was less severe than in hepatitis B recurrence.
1988年9月至1992年11月,我院共进行了318例肝移植手术。这些患者中,68例因非甲非乙型肝炎导致终末期肝硬化,其中44例(64.7%)血清中检测到丙型肝炎病毒RNA。在这个亚组中,35例患者(79.5%)抗-HCV也呈阳性。术后大多数受者抗-HCV仍为阳性,1年后超过90%的患者血清中检测到HCV RNA。约40%的患者发展为轻度慢性肝炎,50%为HCV携带者,无组织病理学迹象。2例患者出现暂时性严重急性肝炎,1例患者因再次感染发生暴发性肝衰竭。总体而言,对于因终末期丙型肝炎接受肝移植的受者,HCV再次感染的发生率较高。然而,其临床过程比乙肝复发要轻。